Medicines: action, dose, metabolism and interactions

Medicines alter processes through specific targets

Pharmacodynamics studies what a medicine does to the body. Many drugs interact with receptors, enzymes, ion channels, or transporters to increase or decrease a process; others work through different physical or chemical mechanisms. An agonist activates a receptor, while an antagonist blocks or reduces another substance’s action there. The outcome also depends on the tissue, signaling pathway, and disease state. Not every medicine works by directly removing a harmful substance.

A target may occur in several tissues, so a drug helping one problem may have unwanted effects elsewhere. Greater potency or intensity does not automatically make a treatment more suitable. Beyond a useful range, additional exposure may mainly add harm. Clinical outcomes establish therapeutic value. A plausible mechanism justifies investigation but does not replace evidence: suppressing a pathway in a laboratory does not prove longer life, fewer symptoms, or better quality of life for patients.

MSD Manual: Drug Action

A dose becomes a changing concentration

Pharmacokinetics studies absorption, distribution, metabolism, and excretion. Swallowing a tablet does not place its entire contents instantly into the circulation. Formulation, route, and other factors affect how quickly the drug is absorbed and what proportion reaches the systemic circulation. Distribution may involve protein binding and movement into different tissues. Effect depends on exposure at the target and its responsiveness, so milligrams are not a universal strength unit for comparing different drugs.

With repeated dosing, remaining drug and newly administered drug together determine concentration. Some medicines take time to reach a relatively stable fluctuation pattern. Declaring failure too early and independently increasing the dose can later produce excessive exposure. Modified-release and enteric-coated products also have specific designs; splitting or crushing requires checking instructions and pharmacist advice. Timing, route, and formulation are part of how the treatment works, not merely packaging details. Changing them can change both benefit and risk.

Source: OpenStax: Pharmacokinetics and Pharmacodynamics

MSD Manual: Drug Absorption

Organ function, metabolites, and half-life

Liver enzymes chemically transform many medicines, while kidneys excrete many drugs or their products. Pathways differ substantially. Metabolism does not always make a drug inactive: some prodrugs require conversion to produce their main effect, and some metabolites remain active or toxic. Changes in liver or kidney function can therefore increase or decrease effects depending on the medicine. Faster metabolism is not a general synonym for better health.

Half-life describes the time required for an amount or concentration to fall by half under specified conditions. It helps explain persistence and dosing schedules but does not mean the effect must end at that moment. Some effects do not track blood concentrations directly. Age, genetics, other medicines, and disease can alter handling. Children are not automatically treated with half an adult dose. Professionals consider indication, body size, organ function, and drug properties; this lesson provides no dose table for independent use.

MSD Manual: Drug Metabolism

MSD Manual: Drug Elimination

Adverse events, reactions, and allergy differ

An adverse event is a health problem occurring during medicine use; the term does not establish that the medicine caused it. Assessing an adverse drug reaction requires consideration of known effects, timing, dose changes, alternatives, and clinical evidence. Allergy is a subset involving an immune mechanism. Nausea, drowsiness, or dizziness should not all be labeled as allergy. A precise account supports safer future treatment choices.

A listed risk does not mean every user will experience it, and a longer list does not by itself prove that one drug is more dangerous. Frequency, severity, and benefit matter. Breathing difficulty, swelling of the tongue or face, collapse, or another severe acute reaction calls for immediate help. For nonemergency suspected effects, record timing and contact the clinician or pharmacist rather than deliberately taking another dose to test causation. Abruptly stopping some long-term medicines also carries risk and requires an appropriate plan.

Source: FDA/ICH E2A: Clinical Safety Data Management—Definitions

FDA: Finding and Learning about Side Effects

Interactions can change exposure or add effects

Pharmacokinetic interactions alter another drug’s absorption, metabolism, distribution, or excretion. Pharmacodynamic interactions alter combined physiological effects even without a major concentration change. Two substances causing sedation, for example, can create greater impairment and respiratory risk together. Foods, alcohol, herbal products, and supplements can also interact, so the list for a visit should include everything actually used, not only prescriptions.

A database interaction alert still requires professional interpretation of severity, exposure, timing, and alternatives. Some combinations can be monitored, while others require adjustment or avoidance; an alert is not a universal instruction to stop treatment independently. Different brands may contain the same active ingredient, particularly in combination cold and pain products. Similar names do not guarantee identical ingredients, and identical ingredients can occur in different strengths or formulations. Knowing the ingredient, purpose, schedule, and combinations to avoid is safer than recognizing package colors.

FDA: Drug Interactions

Reasoning when clearance changes

Zhang has taken a medicine for a long time. Kidney function has recently worsened, and marked drowsiness develops despite an unchanged dose. If the drug or an active metabolite depends substantially on renal clearance, exposure may have increased. That is one mechanism to assess, not a proven explanation: other illness, sleep, or combined medicines could contribute. Contact the team with the symptom timeline, kidney changes, and complete product list. Severe drowsiness or abnormal breathing requires emergency help.

Previous safety does not guarantee that the same regimen remains suitable. Review the current purpose, time to assess benefit, monitoring, and product-specific instructions for missed doses or vomiting. A missed dose should not automatically be replaced with double dosing, and another person’s experience cannot substitute for the individual prescription. Safe use is a continuing process of information and review that aims to avoid preventable harm while retaining treatments with established benefit.

Bilingual terms

药效学 · Pharmacodynamics

Study of what a medicine does to the body.

药代动力学 · Pharmacokinetics

Study of drug absorption, distribution, metabolism, and excretion.

半衰期 · Half-life

Time for drug amount or concentration to fall by half under specified conditions.

活性代谢物 · Active metabolite

A product of drug transformation that retains pharmacological activity.

相互作用 · Interaction

A substance changing another medicine’s exposure or effects.

Sources and further reading

• MSD Manual: Drug Action
• MSD Manual: Drug Metabolism
• FDA: Drug Interactions
• MSD Manual: Drug Elimination
• FDA: Finding and Learning about Side Effects
• MSD Manual: Drug Absorption
• OpenStax: Pharmacokinetics and Pharmacodynamics
• FDA/ICH E2A: Clinical Safety Data Management—Definitions

Original course source-check record: 9 September 2026. Full Chinese and English sentence-by-sentence language review: 14 September 2026. AI editing and language review are not human clinical review. Linked institutions have not participated in or endorsed this course.